How Transcriptomics Revolutionizes Rare Disease Diagnostics

Prof. Peter Bauer, M.D., serves as CENTOGENE’s Chief Medical and Genomic Officer, where he combines clinical and medical understanding in genetic testing with an excellent knowledge of the latest scientific development, based on his extraordinary experience, especially in high-throughput genetic testing using next-generation sequencing. He received his board certification in Human Genetics in 2006 and headed the molecular diagnostic laboratory at the Institute of Medical Genetics and Applied Genomics at the University Hospital Tübingen. Additionally, he is Vice President of the German Society of Neurogenetics (DGNG). Peter has authored more than 250 publications in neurogenetics, oncogenetics, cardiogenetics, and sequencing technology.

Jorge serves as CENTOGENE’s Vice President Medical Genetics. Bringing in over 15 years of leadership experience, he is responsible for overseeing policies, management, and regulations to drive clinical and operational value. Before joining CENTOGENE, Jorge served as the Director of the Molecular Diagnostics and Genomics Labs at CGC Genetics. He holds a medical degree from the University of Porto and is specialized in Rare Disease Genetics, Neurogenetics, Dysmorphology, and Molecular Genetics.